The medical literature was reviewed to identify published trials, case reports, and case series on the use of G-CSF in critically ill patients for treatment of severe sepsis or septic shock.

Dr. John Kellum, Chief Medical Officer of Spectral, stated, “We view December as a transitional month from an enrollment perspective, as the medical supply chain issues eased. Given the continued ...

About 1 hour post clindamycin (second dose overall), and approximately 5 hours after the last metronidazole treatment, skin manifestations were first detected. At this time, the patient became ...

Researchers assessed whether early albumin use among patients with septic shock and kidney impairment upon hospital admission reduced in-hospital mortality or the need for renal replacement therapy ...

The following is a summary of “Impact on fluid balance of an optimized restrictive strategy targeting non-resuscitative fluids in intensive care patients with septic shock: a single-blind, multicenter ...

*The actual case names have been changed for client confidentiality. Settlement amounts are all inclusive amounts (inclusive ...

A Canadian teen is reaching audiences around the world with powerful social media videos showing life without hands and feet ...

Shares of Spectral Medical Inc. (OTCMKTS:EDTXF – Get Free Report) were up 9.1% during trading on Friday . The company traded as high as $0.38 and last traded at $0.38. Approximately 2,562 shares were ...